Cytotoxicity and inhibitory effects of low-concentration triclosan on adipogenic differentiation of human mesenchymal stem cells

Toxicology and Applied Pharmacology

Volumn 262, Issue 2, 2012, Pages 117-123

  Guo, Li Wu ^a   Wu, Qiangen ^a   Green, Bridgett ^a   Nolen, Greg ^a   Shi, Leming ^a   LoSurdo, Jessica ^b   Deng, Helen ^c   Bauer, Steven ^b   Fang, Jia Long ^a   Ning, Baitang ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c ARKANSAS DEPARTMENT OF HEALTH   (United States)

Author keywords

Adipocyte differentiation; Cytotoxicity; Human mesenchymal stem cell; Triclosan

Indexed keywords

ADIPOCYTE PROTEIN 2; ADIPONECTIN; LIPOPROTEIN LIPASE; PROTEIN; TRICLOSAN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID STORAGE; MESENCHYMAL STEM CELL;

ADIPOGENESIS; ADIPONECTIN; ANTI-INFECTIVE AGENTS, LOCAL; AZO COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPOPROTEIN LIPASE; MESENCHYMAL STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRICLOSAN;

EID: 84862255840     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.04.024     Document Type: Article

References (39)

1. Adolfsson-Erici M., Pettersson M., Parkkonen J., Sturve J. Triclosan, a commonly used bactericide found in human milk and in the aquatic environment in Sweden. Chemosphere 2002, 46:1485-1489.
2. Ahn K.C., Zhao B., Chen J., Cherednichenko G., Sanmarti E., Denison M.S., Lasley B., Pessah I.N., Kultz D., Chang D.P.Y., Gee S.J., Hammock B.D. In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. Environ. Health Perspect. 2008, 116:1203-1210.
3. Aiello A.E., Larson E.L., Levy S.B. Consumer antibacterial soaps: effective or just risky?. Clin. Infect. Dis. 2007, 45(Suppl. 2):137-147.
4. Ailhaud G., Amri E.Z., Grimaldi P.A. Fatty acids and adipose cell differentiation. Prostaglandins Leukot. Essent. Fatty Acids 1995, 52:113-115.
5. Allmyr M., Adolfsson-Erici M., McLachlan M.S., Sandborgh-Englund G. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci. Total. Environ. 2006, 372:87-93.
6. Allmyr M., Harden F., Toms L.-M.L., Mueller J.F., McLachlan M.S., Adolfsson-Erici M., Sandborgh-Englund G. The influence of age and gender on triclosan concentrations in Australian human blood serum. Sci. Total. Environ. 2008, 393:162-167.
7. Allmyr M., Panagiotidis G., Sparve E., Diczfalusy U., Sandborgh-Englund G. Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones. Basic Clin. Pharmacol. Toxicol. 2009, 105:339-344.
8. Bagley D.M., Lin Y.J. Clinical evidence for the lack of triclosan accumulation from daily use in dentifrices. Am. J. Dent. 2000, 13:148-152.
9. Brodie A.E., Azarenko V.A., Hu C.Y. Inhibition of increases of transcription factor mRNAs during differentiation of primary rat adipocytes by in vivo 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment. Toxicol. Lett. 1997, 90:91-95.
10. Dann A.B., Hontela A. Triclosan: environmental exposure, toxicity and mechanisms of action. J. Appl. Toxicol. 2011, 31:285-311.
11. Davila J.C., Cezar G.G., Thiede M., Strom S., Miki T., Trosko J. Use and application of stem cells in toxicology. Toxicol. Sci. 2004, 79:214-223.
12. Dayan A.D. Risk assessment of triclosan [Irgasan] in human breast milk. Food Chem. Toxicol. 2007, 45:125-129.
13. DeSalva S.J., Kong B.M., Lin Y.J. Triclosan: a safety profile. Am. J. Dent. 1989, 2:185-196.
14. Fang J.-L., Stingley R.L., Beland F.A., Harrouk W., Lumpkins D.L., Howard P. Occurrence, efficacy, metabolism, and toxicity of triclosan. J. Environ. Sci. Health Part C Environ. Carcinog. Ecotoxicol. Rev. 2010, 28:147-171.
15. Heath R.J., White S.W., Rock C.O. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 2001, 40:467-497.
16. Hu E., Kim J.B., Sarraf P., Spiegelman B.M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 1996, 274:2100-2103.
17. Jacobs M.N., Nolan G.T., Hood S.R. Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol. Appl. Pharmacol. 2005, 209:123-133.
18. James M.O., Li W., Summerlot D.P., Rowland-Faux L., Wood C.E. Triclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta. Environ. Int. 2009, 36:942-949.
19. Jiang Y.H., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J.B., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
20. Jones R.D., Jampani H.B., Newman J.L., Lee A.S. Triclosan: a review of effectiveness and safety in health care settings. Am. J. Infect. Control. 2000, 28:184-196.
21. Kang K.-S., Trosko J.E. Stem cells in toxicology: Fundamental biology and practical considerations. Toxicol. Sci. 2011, 120:S269-S289.
22. Liu B., Wang Y., Fillgrove K.L., Anderson V.E. Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells. Cancer Chemother. Pharmacol. 2002, 49:187-193.
23. Liu P.C.C., Moreno-Aliaga M.J., Dunlap D.Y., Hu X.-M., Denison M.S., Matsumura F. Correlation between the high expression of C/EBPβ protein in F442A cells and their relative resistance to antiadipogenic action of TCDD in comparison to 3T3-L1 cells. J. Biochem. Mol. Toxicol. 2002, 16:70-83.
24. Lu S., Archer M.C. Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. Carcinogenesis 2005, 26:153-157.
25. Lu H., Tonge P.J. Inhibitors of Fabl, an enzyme drug target in the bacterial fatty acid biosynthesis pathway. Acc. Chem. Res. 2008, 41:11-20.
26. Paul K.B., Hedge J.M., DeVito M.J., Crofton K.M. Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in Young Long-Evans rats. Toxicol. Sci. 2010, 113:367-379.
27. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
28. Podechard N., Fardel O., Corolleur M., Bernard M., Lecureur V. Inhibition of human mesenchymal stem cell-derived adipogenesis by the environmental contaminant benzo(a)pyrene. Toxicol. In Vitro 2009, 23:1139-1144.
29. Rodricks J.V., Swenberg J.A., Borzelleca J.F., Maronpot R.R., Shipp A.M. Triclosan: a critical review of the experimental data and development of margins of safety for consumer products. Crit. Rev. Toxicol. 2010, 40:422-484.
30. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 2006, 7:885-896.
31. Sandborgh-Englund G., Adolfsson-Erici M., Odham G., Ekstrand J. Pharmacokinetics of triclosan following oral ingestion in humans. J. Toxicol. Environ. Health 2006, 69:1861-1873.
32. Schmid B., Rippmann J.F., Tadayyon M., Hamilton B.S. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochem. Biophys. Res. Commun. 2005, 328:1073-1082.
33. Stewart J., Bolt H. Stem cells in toxicity testing. Arch. Toxicol. 2011, 85:77-78.
34. Stoker T.E., Gibson E.K., Zorrilla L.M. Triclosan exposure modulates estrogen-dependent responses in the female Wistar rat. Toxicol. Sci. 2010, 117:45-53.
35. Trosko J.E., Chang C.-C. Factors to consider in the use of stem cells for pharmaceutic drug development and for chemical safety assessment. Toxicology 2010, 270:18-34.
36. Wiaderkiewicz R., Czekaj P., Bogus K., Wiaderkiewicz A., Komarska H., Walczuk B., Karpowicz J., Gryz K., Miranowicz K. Differentiation potential of liver mesenchymal stem cells (MSC) from rats exposed to EMF and/or triclosan. Folia. Histochem. Cytobiol. 2007, 45:245-254.
37. Witorsch R.J., Thomas J.A. Personal care products and endocrine disruption: a critical review of the literature. Crit. Rev. Toxicol. 2010, 40:1-30.
38. Wobus A.M., Löser P. Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch. Toxicol. 2011, 85:79-117.
39. Wright H.T., Reynolds K.A. Antibacterial targets in fatty acid biosynthesis. Curr. Opin. Microbiol. 2007, 10:447-453.